c‐Jun phosphorylation in Alzheimer disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The c‐Jun N‐terminal kinase (JNK) pathway is known to be activated by oxidative stress and can lead to either defensive‐protective adaptations in the cell or apoptosis. The JNK pathway is activated in Alzheimer disease (AD), as demonstrated in studies showing higher levels of phospho‐JNK in affected neurons in AD brains than in controls. c‐Jun, a transcription factor, is the downstream effector of JNK, whose activation requires phosphorylation of Ser63/Ser73. In this study, we characterized and compared the localization of c‐Jun phosphorylated at either Ser63 or Ser73 in the hippocampi of AD cases with that in age‐matched controls. Phospho‐c‐Jun (Ser73) was found to be strongly associated with neurofibrillary tangles and granulovacuolar degeneration (GVD) in addition to the nuclei in neurons in the hippocampal regions of the AD brain, but was virtually absent in most controls. Phospho‐c‐Jun (Ser63) was also found to be associated with GVD in AD brains. Indeed, phospho‐c‐Jun (Ser73) immunostaining was much more extensive than that of phospho‐c‐Jun (Ser63), with all the phospho‐c‐Jun (Ser63)–positive neurons also being phospho‐c‐Jun (Ser73) positive. Significant overlap between phospho‐c‐Jun and phospho‐JNK suggested a mechanistic link. In addition, the neurons showing increased levels of phospho‐c‐Jun (Ser73) in the cytoplasmic GVD were negative for TUNEL, suggesting a mechanism protecting the cells from death. Overall, this study demonstrated specific alterations in c‐Jun phosphorylation and distribution in AD which is not necessarily linked to apoptosis but rather may represent an adaptation process in the face of oxidative stress. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789 · cited 1×
“…phospho-c-Jun (Ser63), which may have functional significance because phospho-c-Jun (Ser73) is more important than phospho-c-Jun (Ser63) in transactivation (Smeal et al., 1991, 1994), and phospho-c-Jun (Ser73) appears to be linked to cell survival (Herdegen et al., 1998; Dragunow et al., 2000).”
BackgroundInvolvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611
Self-citationCell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 1×
“This is consistent with the recently achieved consensus that pathological structures like NFTs are not involved in neuronal death (Andorfer et al., 2005; Santacruz et al., 2005).”
ResultGene expression correlates of neurofibrillary tangles in Alzheimer's disease
Dunckley, T., Beach, T. G., Ramsey, K. E., Grover, A., Mastroeni, D., Walker, D. G., LaFleur, B. J., Coon, K. D., Brown, K. M., Caselli, R., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.013 · Cited by 177 · cited 1×
“…neurons displayed gene expression patterns that were distinctively different from those of neurons from the controls, and much of this gene expression is regulated by c-Jun (Dunckley et al., 2006; Lovell et al., 2006), supporting the idea of compensatory adaptation via the JNK–c-Jun pathway.”
Background
Cited by
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
“…studies have suggested that these bodies might derive from the endoplasmic reticulum and represent the stress granules that feature the unfolded protein response, because they are positive for several stress kinases (Zhu et al. 2001; Lagalwar et al. 2007; Thakur et al. 2007; Hoozemans et al. 2009).”
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Akter, K., Lanza, E. A., Martin, S. A., Myronyuk, N., Rua, M., & Raffa, R. B. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03830.x · Cited by 352
Oxidative Stress Signaling in Alzheimers Disease
Su, B., Wang, X., Nunomura, A., Moreira, P., Lee, H.-G., Perry, G., Smith, M., & Zhu, X. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898451 · Cited by 344
Self-citationZhao, W.-Q., & Townsend, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.014 · Cited by 291
Vukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232
“Since c-Jun is a common component of AP-1 protein complex and AP-1 is usually activated as a result of c-Jun phosphorylation (Thakur et al., 2007), we analyzed the effects of Aβ peptides on c-Jun expression and c-Jun phosphorylation in hCMEC/D3 treated with Aβ1–40 peptides.”
BackgroundMethodKnowles, J. K., Rajadas, J., Nguyen, T.-V. V., Yang, T., LeMieux, M. C., Vander Griend, L., Ishikawa, C., Massa, S. M., Wyss-Coray, T., & Longo, F. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0620-09.2009 · Cited by 184
“Quantitation of phosphorylated c-Jun has been established as an indicator of c-jun activation (Smith and Deshmukh, 2007; Thakur et al., 2007; Yang et al., 2008).”
BackgroundJNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis
Huntwork-Rodriguez, S., Wang, B., Watkins, T., Ghosh, A. S., Pozniak, C. D., Bustos, D., Newton, K., Kirkpatrick, D. S., & Lewcock, J. W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201303066 · Cited by 154
JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models
Ploia, C., Antoniou, X., Sclip, A., Grande, V., Cardinetti, D., Colombo, A., Canu, N., Benussi, L., Ghidoni, R., Forloni, G., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110320 · Cited by 145
Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease
Yao, Z., Yang, W., Gao, Z., & Jia, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.027 · Cited by 140
Altered subcellular distribution of c-Abl in Alzheimer’s disease
Jing, Z., Caltagarone, J., & Bowser, R. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1062 · Cited by 83
“Our data suggests a preferential sequestration of Abl-pY412 into GVDs. Sequestering c-Abl in GVDs may represent a neuroprotective response as has been suggested for other proteins that accumulate in GVDs [38].”
Transcriptional and post‐transcriptional regulation of β‐secretase
Tamagno, E., Guglielmotto, M., Monteleone, D., Vercelli, A., & Tabaton, M. (2012) · IUBMB Life · doi:10.1002/iub.1099 · Cited by 40
Yeste-Velasco, M., Folch, J., Casadesús, G., Smith, M. A., Pallàs, M., & Camins, A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.035 · Cited by 31
Self-citation
Metadata
- Authors
- Thakur, A., Wang, X., Siedlak, S. L., Perry, G., Smith, M. A., & Zhu, X.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2007-04-23
- Volume
- 85
- Issue
- 8
- Pages
- 1668-1673
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2169920915
- Cited by
- 81
- References
- 5
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.